Metabolic Disorders, Technology

D-Flex® Injection Pen for GLP-1 Medication

By Haselmeier

Type 2 diabetes is a global health problem. According to expert estimates, the number of patients worldwide will increase by 48% by 2045.

Constantly elevated blood sugar levels mean stress for the blood vessels, which can lead to feared complications, including life-threatening sequelae such as a heart attack, organ failure or stroke.

A consistent treatment of Type 2 diabetes as early as possible can significantly improve the quality of life for the patient and the course of the disease.

Enter your details below to view the free white paper

By downloading this whitepaper, you acknowledge that GlobalData may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how GlobalData may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.